ARTICLE | Clinical News
Virulizin macrophage activator immunostimulant regulatory update
December 4, 2000 8:00 AM UTC
LOR received notice of allowance for a U.S. patent covering a method for the purification of Virulizin from bovine bile. The product is approved in Mexico to treat melanoma and is in Phase II testing ...